Roundup Manufacturer Settles Cancer Suits for $10 Billion

BayerAG, the chemical and pharmaceutical conglomerate, has agreed to pay $10 billion to settle a series of lawsuits brought against it over its signature weed killer, Roundup. The herbicide became the subject of major public controversy after it was discovered that Roundup had carcinogenic properties, a fact that was known by its manufacturer, Monsanto, for decades. The company covered up this fact and continued to sell Roundup to the public, netting billions of dollars from sales of the weed killer in the interim.

Roundup is a chemical herbicide manufactured by Monsanto, which was acquired by BayerAG in 2018. Its primary active ingredient is a chemical called glyphosate, which Monsanto consistently marketed as safe for use in both household and industrial settings. However, recent studies linked the herbicide to non-Hodgkins lymphoma, leading to lawsuits against the company by approximately 125,000 people who believed their lymphoma was caused by exposure to Roundup.

The situation became more alarming when it was revealed that Monsanto had been aware of Roundup’s carcinogenic properties for decades before it became public knowledge. However, Roundup was its signature product and a substantial source of revenue for the company, and so they covered up this information while continuing to sell it to the public. The $10 billion settlement reached by the company will cover about three-quarters of all existing claims against the company, including claims by individuals who have retained an attorney but not yet filed a suit.

If you or someone you love has been sickened or injured due to exposure to glyphosate, you may have legal remedies available to you. The lawyers at Levine and Slavit, PLLC assist clients in collecting the damages they need to cope with injuries and illnesses from harmful and defective products. For more information or to schedule a consultation with our New York personal injury lawyers, call (888) LAW-8088 or fill out our contact form.

Leave a Reply

Your email address will not be published. Required fields are marked *